Clinical resources
Review clinical literature addressing current concepts in
hypoparathyroidism (HPT) and additional resources for healthcare providers.
Downloadable resources

Hypoparathyroidism brochure
An introduction to HPT and the unique challenges of managing this rare condition.

Hypoparathyroidism disease state education
A detailed companion to this website, addressing HPT presentation, complications, and management approach.

Hypoparathyroidism management guidelines
A disease management reference including therapeutic goals and biochemical parameters to be monitored.
Clinical literature
Bilezikian et al.
Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.
Bollerslev et al; European Society of Endocrinology
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults.
Brandi et al.
Management of hypoparathyroidism: Summary statement
and guidelines.
Shoback et al.
Presentation of hypoparathyroidism: Etiologies and
clinical features.
PARADIGHM patient registry
Takeda is a proud sponsor of PARADIGHM, a long-term study that collects data on HPT’s impact to further understand its progression. Patients of any age or gender with a chronic HPT diagnosis are eligible to join.
LEARN MORE ABOUT PARADIGHM